(0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Crystal Gateway Marriott

2026年9月23日 (水) 午前 8:15 - 2026年9月25日 (金) 午後 12:45

1700 Richmond Highway, Arlington, VA 22202, USA

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

参加申し込み

ハイライト＆特長

Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.

What is happening at DIA/FDA Oligonucleotide-Based Therapeutics Conference

  • Learn about the latest advancements, regulatory updates, and emerging trends in oligonucleotide therapies directly from leading industry experts and global regulators
  • Our three tracks (Clinical, Nonclinical, and CMC) will comprehensively cover a wide range of aspects of oligonucleotide therapeutics—from development to regulatory collaboration—and provide practical insights into current challenges and successful strategies for overcoming hurdles in clinical use, safety assessments, and CMC
  • This conference offers a networking opportunity to engage with peers, innovators, and regulators in sessions designed to foster meaningful collaboration and knowledge exchange


PDF Program

Preview all session descriptions, speakers, and more all in one place!

VIEW/PRINT
参加申し込み

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。